Emilia (Xizhu) Liu

Information Technology & Communications Assistant at HAVEN Free Clinic
  • Claim this Profile
Contact Information
Location
New Haven, Connecticut, United States, US

Topline Score

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Credentials

  • Biomedical Research - Basic/Refresher
    CITI Program
    Sep, 2023
    - Sep, 2024
  • HIPAA for Researchers
    Yale University
    Sep, 2023
    - Sep, 2024
  • SQL for Data Science
    Coursera
    Aug, 2023
    - Sep, 2024
  • Conflicts of Interest
    CITI Program
    Oct, 2023
    - Sep, 2024
  • Data or Specimens Only Research
    CITI Program
    Oct, 2023
    - Sep, 2024

Experience

    • United States
    • Hospitals and Health Care
    • 1 - 100 Employee
    • Information Technology & Communications Assistant
      • Sep 2023 - Present
    • Biotechnology
    • 1 - 100 Employee
    • Quantitative Clinical Pharmacology Intern
      • May 2023 - Aug 2023

      - Conducted Model-Based Meta-Analysis using arm-level clinical data from ~200 head and neck cancer clinical trials to facilitate oncology drug development and go-no-go investment decision making - Established robust correlations between early endpoints (ORR) and late endpoints (PFS and OS) by leveraging regression models and data transformation techniques in R, improving R-squared from ~0.3 to ~0.8 - Optimized prediction models of phase III outcomes by performing covariate analysis based on phase II endpoints and 20+ patient characteristics, identifying 5 significant covariates such as age, treatment class, ECOG, etc. - Informed Takeda of significant risk of phase III failure by deriving probability models for achieving Target Product Profiles (TPP) and adjusting TPP for desired Probability of Technical Success, potentially saving ~$30 million Show less

    • United States
    • Hospitals and Health Care
    • 1 - 100 Employee
    • Advisory Board Data Analyst
      • Jan 2023 - May 2023

      - Conduct financial analysis to demonstrate payment inadequacy and its impact on patient outcomes - Perform quantitative analysis, including cost projections and cost-effectiveness analysis, utilizing CT hospice and CMS data - Identify relevant stakeholders, conduct qualitative interviews, and analyze diverse payment models in palliative and hospice care - Research policy precedents and effective means of policy advocacy communication for palliative and hospice care - Develop written communication materials for outreach and stakeholder engagement Show less

    • United States
    • Higher Education
    • 700 & Above Employee
    • Biostatistics Research Assistant
      • Jun 2021 - Aug 2022

      - Discovered feasibility of replacing complex biomarkers with common clinical indices to predict progression of Alzheimer’s Disease (AD) brain pathology and risk of AD at pre-symptomatic stages for living adults; - Optimized 5-year AD risk prediction with Cox Proportional Hazards model and elevated prediction accuracy from 71% to 92%; - Managed AD clinical data with R & Python from cohort studies with 30,000+ participants & 160+ clinical variables; - Employed machine learning (GBM, SVM, Random Forest) & GLM-Elastic Net regression to cross validate models that estimated brain pathology using common clinical indices as predictors; - Compiled two scientific articles and published on Journal of Alzheimer’s Disease and National Institution of Health. Show less

    • France
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Clinical Data Analyst Intern
      • Jun 2021 - May 2022

      - Processed & analyzed prospective longitudinal data collected from 2-year follow-up of 78,000+ patients registered in a patient-centric digital platform for outpatient blood glucose management for Type II Diabetes patients; - Evaluated and validated effectiveness of the digital platform on glucose control and patient compliance to insulin treatment by applying statistical methods such as ANCOVA, Least-Square Means, Logistic Regression; - Improved 3-month outpatient blood glucose control by reducing mean HbA1c from 9.3% to 6.8% and enabling 68.9% of analysis population to reach target healthy level of fasting plasma glucose. Show less

    • Biotechnology Laboratory Assistant
      • May 2020 - Aug 2020

      - Browsed and read 60+ research articles on cutting-edge innovations of CAR-T therapy & CRISPR-Cas technology for leukemia treatment; presented and led discussion on 10+ articles during weekly meetings; - Researched on RNA-guided DNA insertion methods and potential protein biomarkers like CD123, CD5, Mesothelin; - Quantified immune cell sorting experiments using gel electrophoresis & flow cytometry for leukemia biomarkers. - Browsed and read 60+ research articles on cutting-edge innovations of CAR-T therapy & CRISPR-Cas technology for leukemia treatment; presented and led discussion on 10+ articles during weekly meetings; - Researched on RNA-guided DNA insertion methods and potential protein biomarkers like CD123, CD5, Mesothelin; - Quantified immune cell sorting experiments using gel electrophoresis & flow cytometry for leukemia biomarkers.

Education

  • Yale University
    Master's degree, Biostatistics
    2022 - 2024
  • Emory University
    Bachelor of Science - BS, Quantitative Science (Biology Track) and Health Economics
    2019 - 2022

Community

You need to have a working account to view this content. Click here to join now